Surveillance of Antidepressant Safety (SADS): Active Signal Detection of Serious Medical Events Following SSRI and SNRI Initiation Using Big Healthcare Data
Author:
Funder
Novo Nordisk Fonden
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Link
https://link.springer.com/content/pdf/10.1007/s40264-021-01110-x.pdf
Reference37 articles.
1. Onakpoya IJ, Heneghan CJ, Aronson JK. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med [Internet]. 2016;14. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740994/.
2. Gibbons RD, Amatya AK, Brown CH, Hur K, Marcus SM, Bhaumik DK, et al. Post-approval drug safety surveillance. Annu Rev Public Health. 2010;31:419–37.
3. Duijnhoven R, Straus S, Raine J, Boer A, Hoes A, Bruin M. Number of patients studied prior to approval of new medicines: a database analysis. PLoS Med. 2013;10:e1001407.
4. Pacurariu AC, Coloma PM, van Haren A, Genov G, Sturkenboom MCJM, Straus SMJM. A description of signals during the first 18 months of the EMA pharmacovigilance risk assessment committee. Drug Saf. 2014;37(12):1059–66.
5. Platt R, Madre L, Reynolds R, Tilson H. Active drug safety surveillance: a tool to improve public health. Pharmacoepidemiol Drug Saf. 2008;17(12):1175–82.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Antidepressants and COVID-19: Increased use, occurrence in water and effects and consequences on aquatic environment. A review;Science of The Total Environment;2024-11
2. An Intelligent Based IoT System to Predict Proactive Paroxysms Using EDA Sensor;2024 7th International Conference on Devices, Circuits and Systems (ICDCS);2024-04-23
3. Epidemiological surveillance of drug safety using cumulative sequential analysis in electronic healthcare data;Basic & Clinical Pharmacology & Toxicology;2023-11-11
4. Design, synthesis and cytotoxic evaluation of a selective serotonin reuptake inhibitor (SSRI) by virtual screening;European Journal of Pharmaceutical Sciences;2023-04
5. Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting;Pharmacoepidemiology and Drug Safety;2022-09-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3